
  
    
      
        Background_NNP
        Metastasis_NNP of_IN tumor_NN cells_NNS is_VBZ critically_RB dependent_JJ on_IN the_DT
        ability_NN of_IN cancer_NN cells_NNS to_TO adhere_VB and_CC migrate_VB ._. The_DT cell_NN
        surface_NN expressed_VBD integrins_NNS can_MD control_VB this_DT process_NN by_IN
        physically_RB interacting_VBG with_IN the_DT extracellular_NN matrix_NN
        proteins_NNS and_CC other_JJ cell_NN surface_NN proteins_NNS on_IN endothelial_NN
        cells_NNS lining_VBG the_DT blood_NN vessel_NN wall_NN [_NN 1_CD ]_NN ._. These_DT integrins_NNS
        signal_VBP adhesion_NN and_CC migration_NN by_IN communicating_VBG with_IN several_JJ
        tyrosine_NN kinases_NNS inside_IN the_DT cell_NN ,_, including_VBG the_DT Focal_NNP
        Adhesion_NNP Kinase_NNP (_( FAK_NNP )_) and_CC Src_NNP family_NN kinases_NNS [_NN 1_CD 2_CD ]_NN ._. Src_NNP
        kinases_NNS control_VBP the_DT activation_NN of_IN FAK_NNP ,_, as_RB well_RB as_IN the_DT
        tyrosine_NN phosphorylation_NN of_IN critical_JJ substrates_NNS that_WDT
        regulate_VB adhesion_NN and_CC migration_NN [_NN 3_CD ]_NN ._. Indeed_RB ,_, colon_NN
        cancer_NN cells_NNS with_IN high_JJ metastatic_JJ potential_JJ have_VBP elevated_VBD
        levels_NNS of_IN Src_NNP activity_NN or_CC activating_VBG mutations_NNS in_IN the_DT Src_NNP
        gene_NN [_NN 4_CD 5_CD ]_NN ._. One_CD Src_NNP substrate_NN that_WDT is_VBZ involved_VBN in_IN
        regulating_VBG an_DT important_JJ signaling_VBG node_NN in_IN this_DT process_NN is_VBZ
        the_DT adaptor_NN protein_NN p_NN 130_CD 
        cas_NNS (_( Cas_NNP )_) [_NN 6_CD 7_CD 8_CD 9_CD 10_CD ]_NN ._. Cas_NNP
        appears_VBZ to_TO play_VB a_DT central_JJ role_NN in_IN the_DT transformation_NN
        process_NN by_IN several_JJ oncogenes_NNS including_VBG ras_NNS ,_, ornithine_NN
        decarboxylase_NN (_( ODC_NNP )_) ,_, v-_NN Src_NNP ,_, v-crk_JJ ,_, and_CC Bcr-_NNP Abl_NNP ,_, as_IN these_DT
        tumors_NNS all_DT have_VBP elevated_VBD levels_NNS of_IN tyrosine_NN phosphorylated_JJ
        Cas_NNP [_NN 6_CD 11_CD 12_CD 13_CD ]_NN ._. Cells_NNP from_IN mice_NNS that_WDT lack_NN Cas_NNP have_VBP
        much_RB reduced_VBN migration_NN and_CC are_VBP resistant_JJ to_TO transformation_NN
        by_IN v-_NN Src_NNP ,_, while_IN expression_NN of_IN Cas_NNP anti-sense_JJ RNA_NNP in_IN cells_NNS
        transformed_VBN with_IN ras_NNS ,_, v-_NN Src_NNP or_CC ODC_NNP result_NN in_IN reversion_NN of_IN
        the_DT transformed_VBN phenotype_NN [_NN 11_CD 14_CD 15_CD ]_NN ._. Furthermore_RB ,_,
        increased_VBN expression_NN of_IN Cas_NNP can_MD rescue_VB cell_NN migration_NN and_CC
        adhesion_NN in_IN cells_NNS expressing_VBG the_DT tumor_NN suppressor_NN PTEN_NNP ,_, and_CC
        can_MD enhance_VB cell_NN migration_NN and_CC adhesion_NN in_IN normal_JJ cells_NNS ,_,
        with_IN a_DT major_JJ role_NN being_VBG played_VBN by_IN the_DT substrate_NN domain_NN [_NN 16_CD
        17_CD ]_NN ._.
        Cas_NNP is_VBZ a_DT protein_NN which_WDT migrates_NNS with_IN an_DT apparent_JJ mass_NN of_IN
        approximately_RB 130_CD kDa_NN ,_, with_IN a_DT N-_NNP terminal_NN SH_NNP 3_CD domain_NN ,_, a_DT
        central_JJ substrate_NN domain_NN (_( SD_NNP )_) with_IN up_IN to_TO 15_CD tyrosines_NNS which_WDT
        can_MD be_VB phosphorylated_JJ ,_, a_DT C-_NNP terminal_NN region_NN with_IN a_DT
        proline-rich_JJ region_NN ,_, and_CC two_CD tyrosine_NN phosphorylation_NN sites_NNS
        capable_JJ of_IN binding_JJ Src_NNP kinases_NNS (_( Src_NNP binding_JJ domain_NN (_( SBD_NNP )_) )_) [_NN
        6_CD 18_CD ]_NN ._. The_DT latter_JJ SBD_NNP domain_NN regulates_VBZ the_DT ability_NN of_IN Src_NNP
        to_TO activate_VBP the_DT serum_NN response_NN element_NN ,_, as_RB well_RB as_IN in_IN the_DT
        phosphorylation_NN of_IN the_DT SD_NNP of_IN Cas_NNP by_IN Src_NNP [_NN 18_CD 19_CD 20_CD ]_NN ._. The_DT
        substrate_NN domain_NN controls_NNS adhesion_NN and_CC migration_NN and_CC the_DT
        majority_NN of_IN the_DT tyrosines_NNS within_IN this_DT domain_NN are_VBP of_IN the_DT
        sequence_NN YQXP_NNP (_( 5_LS )_) or_CC YDXP_NNP (_( 10_CD )_) ,_, which_WDT when_WRB phosphorylated_JJ ,_,
        bind_NN to_TO the_DT adaptors_NNS c-crk_JJ ,_, nck_NN and_CC AND-_NNP 34_CD [_NN 16_CD 21_CD 22_CD 23_CD ]_NN
        ._. The_DT importance_NN of_IN these_DT molecules_NNS in_IN Cas_NNP function_NN is_VBZ
        unclear_JJ ,_, however_RB c-crk_JJ seems_VBZ to_TO be_VB critical_JJ in_IN the_DT
        regulation_NN of_IN adhesion_NN and_CC migration_NN mediated_JJ by_IN Cas_NNP ._. In_IN
        addition_NN ,_, the_DT SH_NNP 3_CD domain_NN of_IN Cas_NNP mediates_NNS an_DT interaction_NN
        with_IN FAK_NNP ,_, C_NNP 3_CD G_NNP ,_, CMS_NNP ,_, and_CC the_DT zinc_NN finger_NN containing_VBG protein_NN
        CIZ_NNP ,_, while_IN nephrocystin_NN interacts_NNS with_IN Cas_NNP via_IN its_PRP$ SH_NNP 3_CD
        domain_NN and_CC proline_NN rich_JJ sequences_NNS in_IN Cas_NNP [_NN 24_CD 25_CD 26_CD 27_CD 28_CD
        29_CD 30_CD ]_NN ._. The_DT SH_NNP 3_CD domain_NN of_IN Cas_NNP can_MD also_RB interact_NN with_IN the_DT
        tyrosine_NN phosphatase_NN PTP_NNP 1_CD B_NNP ,_, and_CC expression_NN of_IN PTP_NNP 1_CD B_NNP in_IN
        transformed_VBN cells_NNS reverts_VBZ the_DT phenotype_NN ,_, in_IN part_NN by_IN
        dephosphorylating_VBG Cas_NNP [_NN 31_CD 32_CD ]_NN ._.
        Tyrosine_NNP phosphorylation_NN of_IN Cas_NNP is_VBZ regulated_VBN by_IN
        adhesion_NN ,_, such_JJ that_DT adherent_NN and_CC migrating_VBG cells_NNS have_VBP high_JJ
        levels_NNS of_IN tyrosine_NN phosphorylated_JJ Cas_NNP ,_, whereas_IN cells_NNS in_IN
        suspension_NN have_VBP reduced_VBN levels_NNS of_IN Cas_NNP phosphorylation_NN [_NN 10_CD
        33_CD ]_NN ._. In_IN addition_NN ,_, as_IN mentioned_VBN above_IN ,_, transformed_VBN cells_NNS
        that_WDT are_VBP able_JJ to_TO grow_VB in_IN an_DT anchorage_NN independent_JJ manner_NN
        show_NN increased_VBD tyrosine_NN phosphorylation_NN of_IN Cas_NNP [_NN 10_CD 33_CD ]_NN ._.
        These_DT data_NNS suggest_VBP that_DT tyrosine_NN phosphorylation_NN of_IN Cas_NNP in_IN
        part_NN regulates_VBZ a_DT switch_NN from_IN adhesion_NN dependent_JJ growth_NN to_TO
        adhesion_NN independent_JJ growth_NN ._. Whether_IN mere_JJ tyrosine_NN
        phosphorylation_NN or_CC localization_NN of_IN Cas_NNP is_VBZ more_RBR important_JJ
        for_IN its_PRP$ regulation_NN of_IN adhesion_NN and_CC migration_NN is_VBZ unclear_JJ ._.
        Tyrosine_NNP phosphorylation_NN of_IN adaptor_NN molecules_NNS such_JJ as_IN Cas_NNP
        is_VBZ dependent_JJ on_IN upstream_JJ signals_VBZ that_WDT lead_VBP to_TO the_DT
        phosphorylation_NN of_IN the_DT adaptor_NN ,_, and_CC with_IN multiple_JJ pathways_NNS
        leading_VBG from_IN these_DT upstream_JJ signals_VBZ it_PRP is_VBZ difficult_JJ to_TO
        tease_NN out_RP the_DT events_NNS resulting_VBG from_IN the_DT phosphorylated_JJ
        adaptor_NN itself_PRP ._. We_PRP have_VBP tried_VBN to_TO address_VB this_DT problem_NN by_IN
        constructing_VBG a_DT chimeric_JJ Cas_NNP molecule_NN (_( Src_NNP *_NN /_NN Cas_NNP (_( SD_NNP )_) )_) that_WDT is_VBZ
        phosphorylated_JJ independently_RB of_IN upstream_JJ signals_VBZ by_IN fusing_NN
        the_DT SD_NNP of_IN Cas_NNP to_TO a_DT Src_NNP kinase_NN domain_NN that_WDT had_VBD been_VBN
        attenuated_JJ by_IN mutating_VBG the_DT activation_NN tyrosine_NN (_( Y_NNP 416_CD )_) to_TO
        phenylalanine_NN ._. Such_JJ a_DT mutant_JJ is_VBZ inactive_JJ against_IN exogenous_JJ
        substrates_NNS [_NN 34_CD 35_CD 36_CD ]_NN ._. We_PRP found_VBD that_IN this_DT Src_NNP *_NN /_NN Cas_NNP (_( SD_NNP )_)
        molecule_NN is_VBZ constitutively_RB tyrosine_NN phosphorylated_JJ when_WRB
        expressed_VBD either_CC transiently_RB or_CC stably_RB in_IN cells_NNS ,_, and_CC acts_NNS
        as_IN a_DT dominant_JJ negative_JJ mutant_JJ ,_, attenuating_VBG v-crk_JJ mediated_JJ
        transformation_NN when_WRB expressed_VBD in_IN cells_NNS transformed_VBN by_IN this_DT
        oncogene_NN ._. We_PRP also_RB observed_VBD a_DT reduction_NN in_IN basal_NN JNK_NNP
        activity_NN in_IN normal_JJ cells_NNS expressing_VBG this_DT chimera_NN and_CC in_IN
        v-crk_JJ mediated_JJ activation_NN of_IN JNK_NNP in_IN cell_NN expressing_VBG both_DT
        v-crk_JJ and_CC the_DT chimera_NN ._. By_IN contrast_NN ,_, tyrosine_NN
        phosphorylation_NN of_IN endogenous_JJ Cas_NNP and_CC FAK_NNP was_VBD unaffected_JJ by_IN
        the_DT Cas_NNP chimera_NN ,_, indicating_VBG that_IN these_DT processes_VBZ lie_NN
        upstream_RB of_IN the_DT tyrosine_NN phosphorylated_JJ Cas_NNP SD_NNP ._. Finally_RB ,_, we_PRP
        show_VBP that_IN this_DT chimera_NN can_MD act_VB as_IN a_DT decoy_NN to_TO selectively_RB
        disrupt_VB signaling_VBG events_NNS downstream_JJ of_IN the_DT tyrosine_NN
        phosphorylated_JJ SD_NNP of_IN endogenous_JJ Cas_NNP ,_, acting_VBG as_IN a_DT dominant_JJ
        negative_JJ mutant_JJ ._. We_PRP suggest_VBP that_IN this_DT approach_NN and_CC modified_VBN
        versions_NNS of_IN this_DT approach_NN can_MD be_VB a_DT general_JJ method_NN to_TO
        determine_VB the_DT role_NN of_IN tyrosine_NN phosphorylated_JJ domains_NNS
        without_IN regard_NN to_TO upstream_RB signals_VBZ ._.
      
      
        Results_NNS
        
          Creation_NN of_IN a_DT dominantly_RB tyrosine_NN phosphorylated_JJ
          Cas_NNP substrate_NN domain_NN
          The_DT adaptor_NN protein_NN Cas_NNP has_VBZ a_DT N-_NNP terminal_NN SH_NNP 3_CD domain_NN ,_, a_DT
          large_JJ number_NN of_IN tyrosines_NNS that_WDT serve_VBP as_IN potential_JJ kinase_NN
          substrates_NNS within_IN its_PRP$ substrate_NN domain_NN and_CC a_DT C-_NNP terminal_NN
          Src_NNP binding_JJ domain_NN (_( Fig_NNP ._. 1_LS )_) ._. Understanding_NNP the_DT function_NN
          of_IN this_DT substrate_NN domain_NN and_CC the_DT tyrosines_NNS within_IN it_PRP
          could_MD lead_VB to_TO a_DT better_JJR understanding_NN of_IN the_DT signaling_VBG
          pathways_NNS regulated_VBN by_IN this_DT protein_NN ._. Previously_RB ,_,
          investigators_NNS have_VBP created_VBN dominant_JJ negative_JJ versions_NNS of_IN
          this_DT protein_NN lacking_VBG its_PRP$ substrate_NN domain_NN and_CC shown_VBN that_IN
          it_PRP is_VBZ required_VBN for_IN cell_NN adhesion_NN and_CC migration_NN ._. However_RB ,_,
          these_DT studies_NNS depend_VBP on_IN upstream_JJ signals_NNS and_CC so_IN it_PRP is_VBZ not_RB
          clear_JJ which_WDT signals_NNS are_VBP directly_RB emanating_VBG from_IN the_DT
          substrate_NN domain_NN itself_PRP ,_, as_IN this_DT domain_NN requires_VBZ the_DT
          activation_NN of_IN upstream_JJ kinases_NNS for_IN its_PRP$ phosphorylation_NN
          and_CC function_NN ._. We_PRP have_VBP tried_VBN to_TO address_VB this_DT problem_NN by_IN
          attempting_VBG to_TO create_VB a_DT dominant_JJ active_JJ substrate_NN domain_NN
          of_IN Cas_NNP ,_, i_NNP ._. e_SYM ._. a_DT Cas_NNP substrate_NN domain_NN that_WDT is_VBZ
          constitutively_RB tyrosine_NN phosphorylated_JJ and_CC able_JJ to_TO send_VB
          signals_NNS independently_RB of_IN upstream_JJ signals_VBZ ._. We_PRP did_VBD this_DT by_IN
          fusing_NN the_DT SD_NNP of_IN Cas_NNP to_TO a_DT Src_NNP kinase_NN domain_NN that_WDT had_VBD been_VBN
          attenuated_JJ by_IN mutating_VBG the_DT activation_NN tyrosine_NN (_( Y_NNP 416_CD )_) to_TO
          phenylalanine_NN (_( Src_NNP *_NN /_NN Cas_NNP (_( SD_NNP )_) ,_, Fig_NNP ._. 2_LS )_) ._. This_DT Src_NNP mutant_JJ is_VBZ
          inactive_JJ against_IN exogenous_JJ substrates_NNS [_NN 34_CD 35_CD 36_CD ]_NN ._. We_PRP
          also_RB generated_VBD fusions_NNS of_IN the_DT Cas_NNP SD_NNP with_IN a_DT Src_NNP kinase_NN
          inactive_JJ mutant_JJ (_( K_NNP 295_CD M_NNP )_) that_WDT has_VBZ no_DT enzymatic_JJ activity_NN
          (_( Src_NNP KM_NNP /_NN Cas_NNP (_( SD_NNP )_) )_) ,_, fusions_NNS of_IN either_DT the_DT attenuated_JJ kinase_NN
          domain_NN or_CC kinase_NN inactive_JJ domain_NN to_TO the_DT 5_CD '_POS or_CC 3_CD '_POS regions_NNS
          of_IN the_DT Cas_NNP SD_NNP (_( Src_NNP *_NN /_NN Cas_NNP (_( 5_CD '_POS SD_NNP )_) ,_, Src_NNP *_NN /_NN Cas_NNP (_( 3_CD '_POS SD_NNP )_) ,_, Src_NNP
          KM_NNP /_NN Cas_NNP (_( 5_CD '_POS SD_NNP )_) ,_, Src_NNP KM_NNP /_NN Cas_NNP (_( 3_CD '_POS SD_NNP )_) )_) ,_, as_RB well_RB as_IN the_DT
          attenuated_JJ Src_NNP kinase_NN (_( Src_NNP *_NN )_) alone_RB without_IN the_DT attached_VBN
          Cas_NNP SD_NNP (_( Fig_NNP ._. 2_LS )_) ._. Transient_NNP expression_NN of_IN the_DT Src_NNP *_NN /_NN Cas_NNP (_( SD_NNP )_)
          in_IN Cos-_NNP 7_CD cells_NNS followed_VBN by_IN analysis_NN of_IN total_JJ cell_NN lysates_NNS
          using_VBG anti-phosphotyrosine_JJ antibodies_NNS demonstrated_VBN that_IN
          while_IN the_DT attenuated_JJ Src_NNP kinase_NN domain_NN alone_RB did_VBD not_RB
          increase_VB total_JJ cellular_JJ tyrosine_NN phosphorylated_JJ proteins_NNS
          as_IN expected_VBN ,_, expression_NN of_IN the_DT Src_NNP *_NN /_NN Cas_NNP (_( SD_NNP )_) fusion_NN
          resulted_VBD in_IN tyrosine_NN phosphorylation_NN of_IN a_DT protein_NN of_IN the_DT
          expected_VBN size_NN of_IN the_DT chimera_NN ,_, as_RB well_RB as_IN other_JJ proteins_NNS
          (_( Fig_NNP ._. 3_LS a_DT ,_, 3_CD b_SYM )_) ._. Expression_NNP of_IN the_DT Cas_NNP (_( SD_NNP )_) or_CC the_DT Src_NNP
          KM_NNP /_NN Cas_NNP (_( SD_NNP )_) ,_, fusion_NN did_VBD not_RB result_VB in_IN any_DT increase_NN in_IN
          total_JJ phosphotyrosine_NN containing_VBG proteins_NNS nor_CC in_IN the_DT
          tyrosine_NN phosphorylation_NN of_IN the_DT Cas_NNP SD_NNP (_( data_NNS not_RB shown_VBN
          and_CC see_VB Fig_NNP ._. 4_LS )_) ._.
        
        
          The_DT C-_NNP terminus_JJ of_IN the_DT Cas_NNP SD_NNP is_VBZ involved_VBN in_IN the_DT
          interaction_NN with_IN v-crk_JJ
          Investigators_NNS have_VBP shown_VBN that_IN v-crk_JJ interacts_NNS via_IN its_PRP$
          SH_NNP 2_CD domain_NN with_IN the_DT substrate_NN domain_NN of_IN Cas_NNP [_NN 6_CD ]_NN ._.
          Association_NNP of_IN v-crk_JJ with_IN endogenous_JJ Cas_NNP is_VBZ believed_VBN to_TO
          protect_VB the_DT phosphorylation_NN status_NN of_IN this_DT molecule_NN due_JJ
          to_TO protection_NN from_IN phosphatases_NNS [_NN 12_CD ]_NN ._. Expression_NNP of_IN an_DT
          unphosphorylated_JJ Cas_NNP SD_NNP along_IN with_IN v-crk_JJ should_MD therefore_RB
          result_VB in_IN stable_JJ tyrosine_NN phosphorylation_NN of_IN the_DT Cas_NNP SD_NNP
          if_IN they_PRP interact_NN ._. The_DT Cas_NNP SD_NNP has_VBZ two_CD sets_NNS of_IN potential_JJ
          SH_NNP 2_CD interacting_VBG tyrosines_NNS ,_, the_DT N-_NNP terminal_NN subdomain_NN
          containing_VBG 4_CD YQXP_NNP motifs_NNS located_VBN between_IN a_DT ._. a_DT ._. L_NNP 157_CD to_TO A_DT
          324_CD and_CC the_DT C-_NNP terminal_NN subdomain_NN containing_VBG ,_, 9_CD YDXP_NNP motifs_NNS
          located_VBN between_IN a_DT ._. a_DT ._. S_NNP 325_CD to_TO R_NN 516_CD ._. The_DT v-crk_JJ SH_NNP 2_CD domain_NN
          interacts_NNS with_IN YXXP_NNP motifs_NNS upon_IN phosphorylation_NN ,_,
          suggesting_VBG that_IN both_DT of_IN these_DT regions_NNS may_MD be_VB able_JJ to_TO
          interact_NN with_IN v-crk_JJ [_NN 37_CD ]_NN ._. Fusions_NNP of_IN the_DT kinase_NN
          inactive_JJ Src_NNP kinase_NN domain_NN and_CC either_CC the_DT full_JJ Cas_NNP SD_NNP ,_,
          the_DT 5_CD '_POS region_NN of_IN the_DT Cas_NNP SD_NNP (_( Cas_NNP (_( 5_CD '_POS SD_NNP )_) ,_, containing_VBG 4_CD YQXP_NNP
          motifs_NNS )_) or_CC the_DT 3_CD '_POS of_IN the_DT Cas_NNP SD_NNP (_( Cas_NNP (_( 3_CD '_POS SD_NNP )_) ,_, containing_VBG 9_CD
          YDXP_NNP motifs_NNS )_) ,_, are_VBP not_RB stably_RB tyrosine_NN phosphorylated_JJ when_WRB
          expressed_VBD alone_RB in_IN cells_NNS (_( data_NNS not_RB shown_VBN and_CC see_VB Fig_NNP ._.
          4_LS b_SYM )_) ._. We_PRP therefore_RB used_VBD these_DT fusions_NNS to_TO determine_VB which_WDT
          region_NN of_IN the_DT Cas_NNP SD_NNP interacts_NNS with_IN v-crk_JJ ._. Initially_RB ,_, we_PRP
          expressed_VBD the_DT Src_NNP KM_NNP /_NN Cas_NNP (_( SD_NNP )_) (_( entire_JJ Cas_NNP SD_NNP )_) in_IN Cos-_NNP 7_CD
          cells_NNS alone_RB ,_, or_CC along_IN with_IN wild_JJ type_NN (_( WT_NNP )_) v-crk_JJ ,_, or_CC v-crk_JJ
          SH_NNP 2_CD or_CC SH_NNP 3_CD mutants_NNS and_CC assayed_JJ for_IN tyrosine_NN
          phosphorylation_NN and_CC association_NN by_IN co-immunoprecipitation_JJ
          (_( Fig_NNP ._. 4_LS a_DT )_) ._. Figure_NN 4_CD ademonstrates_NNS that_IN while_IN the_DT chimera_NN
          was_VBD not_RB stably_RB tyrosine_NN phosphorylated_JJ when_WRB expressed_VBD
          alone_RB ,_, expression_NN of_IN the_DT Src_NNP KM_NNP /_NN Cas_NNP (_( SD_NNP )_) chimera_NN along_IN
          with_IN either_DT WT_NNP or_CC an_DT SH_NNP 3_CD domain_NN mutant_JJ of_IN v-crk_JJ resulted_VBD
          in_IN its_PRP$ stable_JJ tyrosine_NN phosphorylation_NN and_CC
          co-immunoprecipitation_JJ with_IN v-crk_JJ (_( Fig_NNP ._. 4_LS a_DT ,_, lanes_NNS 2_CD &_CC
          4_LS )_) ._. However_RB ,_, co-expression_JJ of_IN the_DT Src_NNP KM_NNP /_NN Cas_NNP (_( SD_NNP )_) chimera_NN
          along_IN with_IN a_DT SH_NNP 2_CD mutant_JJ of_IN v-crk_JJ demonstrated_VBN that_IN an_DT
          intact_JJ v-crk_JJ SH_NNP 2_CD domain_NN is_VBZ required_VBN for_IN association_NN with_IN
          the_DT tyrosine_NN phosphorylated_JJ Src_NNP KM_NNP /_NN Cas_NNP (_( SD_NNP )_) (_( Fig_NNP ._. 4_LS a_DT ,_, lane_NN
          3_LS )_) ._. These_DT data_NNS suggest_VBP that_IN the_DT kinase_NN inactive_JJ fusion_NN
          with_IN the_DT Cas_NNP SD_NNP is_VBZ either_CC transiently_RB tyrosine_NN
          phosphorylated_JJ in_IN cells_NNS and_CC v-crk_JJ protects_VBZ them_PRP from_IN
          being_VBG dephosphorylated_JJ by_IN interacting_VBG with_IN them_PRP via_IN its_PRP$
          SH_NNP 2_CD domain_NN ,_, or_CC alternatively_RB ,_, that_IN v-crk_JJ induces_VBZ their_PRP$
          tyrosine_NN phosphorylation_NN ._.
          We_PRP then_RB used_VBD the_DT 5_CD '_POS and_CC 3_CD '_POS fusions_NNS of_IN the_DT Cas_NNP SD_NNP to_TO
          determine_VB which_WDT motif_NN ,_, YQXP_NNP or_CC YDXP_NNP ,_, interacts_NNS with_IN the_DT
          v-crk_JJ SH_NNP 2_CD domain_NN ._. Expression_NNP of_IN the_DT Src_NNP KMfused_NNP to_TO the_DT
          full_JJ length_NN Cas_NNP SD_NNP ,_, 5_CD '_POS N-_NNP terminal_NN YQXP_NNP motifs_NNS or_CC 3_CD '_POS
          C-_NNP terminal_NN YDXP_NNP motifs_NNS alone_RB demonstrated_VBN that_IN these_DT
          fusions_NNS were_VBD not_RB stably_RB tyrosine_NN phosphorylated_JJ in_IN cells_NNS
          (_( Fig_NNP ._. 4_LS b_SYM ,_, lanes_NNS 1_CD -_: 3_LS )_) ,_, although_IN they_PRP can_MD be_VB stably_RB
          tyrosine_NN phosphorylated_JJ when_WRB fused_JJ to_TO the_DT attenuated_JJ Src_NNP
          kinase_NN domain_NN (_( data_NNS not_RB shown_VBN and_CC see_VB Fig_NNP ._. 7_CD a_DT )_) ._. By_IN
          contrast_NN ,_, co-expression_JJ of_IN these_DT fusions_NNS along_IN with_IN v-crk_JJ
          results_NNS in_IN stable_JJ tyrosine_NN phosphorylation_NN of_IN the_DT 3_CD '_POS
          C-_NNP terminal_NN YDXP_NNP motifs_NNS and_CC the_DT full_JJ length_NN Cas_NNP SD_NNP
          (_( carrying_VBG both_DT motifs_NNS )_) ,_, but_CC not_RB the_DT 5_CD '_POS N-_NNP terminal_NN YQXP_NNP
          motifs_NNS (_( Fig_NNP ._. 4_LS b_SYM ,_, lanes_NNS 4_CD -_: 6_CD )_) ._. These_DT data_NNS indicate_VBP that_IN the_DT
          v-crk_JJ SH_NNP 2_CD domain_NN interacts_NNS with_IN the_DT C-_NNP terminal_NN YDXP_NNP
          motifs_NNS ,_, and_CC as_IN suggested_VBN by_IN Birge_NNP et_CC al_NN ,_, v-crk_JJ may_MD be_VB
          able_JJ to_TO protect_VB them_PRP from_IN dephosphorylation_NN and_CC /_NN or_CC
          induces_VBZ their_PRP$ phosphorylation_NN [_NN 12_CD ]_NN ._. They_PRP also_RB suggest_VBP
          that_IN the_DT YQXP_NNP motifs_NNS may_MD be_VB involved_VBN in_IN binding_JJ to_TO other_JJ
          intracellular_NN signaling_VBG molecules_NNS ._.
        
        
          Suppression_NN of_IN v-crk_JJ mediated_JJ transformation_NN by_IN
          tyrosine_NN phosphorylated_JJ Cas_NNP SD_NNP
          As_IN our_PRP$ tyrosine_NN phosphorylated_JJ Cas_NNP SD_NNP chimera_NN can_MD
          interact_NN with_IN v-crk_JJ ,_, we_PRP decided_VBD to_TO find_VB out_IN if_IN the_DT
          chimera_NN would_MD affect_VB cell_NN growth_NN and_CC /_NN or_CC transformation_NN in_IN
          normal_JJ cells_NNS and_CC those_DT transformed_VBN with_IN v-crk_JJ ._. NIH_NNP 3_CD T_NN 3_CD
          cells_NNS or_CC those_DT transformed_VBN with_IN v-crk_JJ were_VBD stably_RB
          transfected_JJ with_IN the_DT Cas_NNP SD_NNP chimera_NN (_( Fig_NNP ._. 5_LS )_) ._. Several_JJ
          independent_JJ clones_NNS were_VBD obtained_VBN for_IN each_DT set_NN of_IN
          transfections_NNS suggesting_VBG that_DT expression_NN of_IN the_DT tyrosine_NN
          phosphorylated_JJ Cas_NNP SD_NNP domain_NN did_VBD not_RB negatively_RB affect_VB
          cell_NN growth_NN (_( data_NNS not_RB shown_VBN )_) ._. Figure_NN 5_CD ademonstrates_NNS that_IN
          stable_JJ expression_NN of_IN the_DT Src_NNP *_NN /_NN Cas_NNP (_( SD_NNP )_) chimera_NN resulted_VBD in_IN
          constitutive_JJ tyrosine_NN phosphorylation_NN of_IN this_DT protein_NN in_IN
          NIH_NNP 3_CD T_NN 3_CD cells_NNS ._. Analysis_NNP of_IN the_DT effect_NN of_IN this_DT chimera_NN in_IN
          non-transformed_JJ NIH_NNP 3_CD T_NN 3_CD cells_NNS indicates_VBZ that_IN these_DT cells_NNS
          were_VBD not_RB transformed_VBN and_CC had_VBN normal_JJ morphology_NN ,_, although_IN
          they_PRP grew_VBD slightly_RB slower_JJR than_IN vector-transfected_JJ cells_NNS
          (_( data_NNS not_RB shown_VBN )_) ._. Analysis_NNP of_IN the_DT growth_NN of_IN either_DT
          non-transformed_JJ or_CC v-crk_JJ transformed_VBN NIH_NNP 3_CD T_NN 3_CD cells_NNS in_IN soft_JJ
          agar_NN confirmed_VBD that_DT expression_NN of_IN tyrosine_NN phosphorylated_JJ
          Cas_NNP SD_NNP chimera_NN did_VBD not_RB transform_VB NIH_NNP 3_CD T_NN 3_CD cells_NNS as_IN no_DT
          colonies_NNS of_IN these_DT cells_NNS grew_VBD in_IN soft_JJ agar_NN (_( data_NNS not_RB
          shown_VBN )_) ._. Instead_RB ,_, expression_NN of_IN tyrosine_NN phosphorylated_JJ
          Cas_NNP SD_NNP chimera_NN resulted_VBD in_IN significant_JJ reduction_NN in_IN the_DT
          number_NN of_IN v-crk_JJ /_NN NIH_NNP 3_CD T_NN 3_CD soft_JJ agar_NN colonies_NNS as_RB well_RB as_IN
          their_PRP$ size_NN (_( Fig_NNP ._. 5_LS b_SYM )_) ,_, suggesting_VBG that_IN the_DT Src_NNP *_NN /_NN Cas_NNP (_( SD_NNP )_)
          chimera_NN blocked_VBD the_DT ability_NN of_IN v-crk_JJ to_TO transform_VB these_DT
          cells_NNS ._.
        
        
          Tyrosine_NNP phosphorylated_JJ Cas_NNP SD_NNP blocks_NNS JNK_NNP
          activation_NN by_IN v-crk_JJ
          The_DT JNK_NNP pathway_NN is_VBZ regulated_VBN by_IN interaction_NN of_IN c-_NN or_CC
          v-crk_JJ with_IN Cas_NNP via_IN the_DT substrate_NN domain_NN [_NN 38_CD ]_NN ._. In_IN
          determining_VBG which_WDT pathways_NNS are_VBP affected_VBN in_IN our_PRP$ stable_JJ
          cell_NN lines_NNS generated_VBN ,_, we_PRP determined_VBD if_IN JNK_NNP was_VBD activated_VBN
          in_IN the_DT v-crk_JJ transformed_VBN cells_NNS ,_, and_CC if_IN the_DT tyrosine_NN
          phosphorylated_JJ Cas_NNP chimera_NN was_VBD affecting_VBG this_DT activation_NN ._.
          JNK_NNP was_VBD immunoprecipitated_JJ and_CC tested_VBN for_IN activity_NN from_IN
          control_NN NIH_NNP 3_CD T_NN 3_CD cells_NNS ,_, those_DT expressing_VBG the_DT Cas_NNP chimera_NN
          and_CC those_DT expressing_VBG the_DT Cas_NNP chimera_NN and_CC v-crk_JJ (_( Fig_NNP ._. 6_CD a_DT )_) ._.
          We_PRP found_VBD that_IN while_IN JNK_NNP activity_NN was_VBD elevated_VBD in_IN v-crk_JJ
          transformed_VBN NIH_NNP 3_CD T_NN 3_CD cells_NNS ,_, expression_NN of_IN the_DT tyrosine_NN
          phosphorylated_JJ Cas_NNP chimera_NN resulted_VBD in_IN reduced_VBN activity_NN
          of_IN JNK_NNP (_( Fig_NNP ._. 6_CD a_DT ,_, cf_NN ._. lanes_NNS 1_CD ,_, 5_CD and_CC 7_CD )_) ._. Interestingly_RB ,_,
          JNK_NNP activity_NN was_VBD also_RB lower_JJR in_IN the_DT NIH_NNP 3_CD T_NN 3_CD cells_NNS
          expressing_VBG the_DT tyrosine_NN phosphorylated_JJ Cas_NNP chimera_NN than_IN
          the_DT vector_NN transfected_JJ cells_NNS ,_, suggesting_VBG that_IN this_DT
          chimera_NN also_RB affected_VBD JNK_NNP activity_NN in_IN those_DT cells_NNS (_( Fig_NNP ._.
          6_CD a_DT ,_, cf_NN ._. lanes_NNS 1_CD and_CC 4_LS )_) ._. These_DT data_NNS suggest_VBP that_IN the_DT
          tyrosine_NN phosphorylated_JJ Cas_NNP chimera_NN perturbs_NNS signaling_VBG
          via_IN v-crk_JJ and_CC probably_RB via_IN endogenous_JJ c-crk_JJ to_TO affect_VB the_DT
          activation_NN of_IN the_DT JNK_NNP pathway_NN ._.
          We_PRP also_RB verified_VBN that_IN the_DT tyrosine_NN phosphorylated_JJ Cas_NNP
          chimera_NN could_MD affect_VB the_DT ability_NN of_IN v-crk_JJ to_TO activate_VBP the_DT
          JNK_NNP pathway_NN in_IN transient_JJ transfection_NN experiments_NNS (_( Fig_NNP ._.
          6_CD b_SYM )_) ._. Transfection_NNP of_IN v-crk_JJ along_IN with_IN gst-_NN JNK_NNP into_IN Cos-_NNP 7_CD
          cells_NNS resulted_VBD in_IN activation_NN of_IN the_DT co-transfected_JJ JNK_NNP
          (_( Fig_NNP ._. 6_CD b_SYM ,_, cf_NN ._. lanes_NNS 1_CD and_CC 2_LS )_) ._. However_RB ,_, co-transfection_JJ of_IN
          v-crk_JJ and_CC gst-_NN JNK_NNP with_IN the_DT tyrosine_NN phosphorylated_JJ Cas_NNP
          chimera_NN blocked_VBD the_DT activation_NN of_IN JNK_NNP induced_VBN by_IN v-crk_JJ
          (_( Fig_NNP ._. 6_CD b_SYM ,_, cf_NN ._. lanes_NNS 2_CD &_CC 3_LS )_) ,_, confirming_VBG that_DT tyrosine_NN
          phosphorylated_JJ Cas_NNP SD_NNP can_MD inhibit_VB the_DT ability_NN of_IN v-crk_JJ to_TO
          activate_VBP the_DT JNK_NNP pathway_NN ._. Transient_NNP expression_NN of_IN the_DT
          Src_NNP *_NN increased_VBD JNK_NNP activity_NN slightly_RB while_IN expression_NN of_IN
          the_DT Src_NNP KM_NNP /_NN Cas_NNP (_( SD_NNP )_) fusion_NN did_VBD not_RB affect_VB JNK_NNP activity_NN
          (_( data_NNS not_RB shown_VBN )_) ._.
          To_TO determine_VB if_IN the_DT tyrosine-phosphorylated_JJ Cas_NNP SD_NNP
          chimera_NN affected_VBD other_JJ signaling_VBG pathways_NNS ,_, we_PRP tested_VBD
          whether_IN the_DT association_NN between_IN c-crk_JJ and_CC C_NNP 3_CD G_NNP was_VBD
          affected_VBN in_IN NIH_NNP 3_CD T_NN 3_CD cells_NNS expressing_VBG the_DT chimera_NN (_( Fig_NNP ._.
          7_CD a_DT )_) ._. Immunoprecipitating_NNP endogenous_JJ c-crk_JJ and_CC probing_VBG for_IN
          associated_VBN C_NNP 3_CD G_NNP demonstrated_VBD that_IN C_NNP 3_CD G_NNP association_NN with_IN
          c-crk_JJ was_VBD reduced_VBN in_IN the_DT presence_NN of_IN the_DT tyrosine_NN
          phosphorylated_JJ chimera_NN (_( Fig_NNP ._. 7_CD a_DT ,_, cf_NN ._. lanes_NNS 3_CD ,_, 4_CD &_CC 5_LS )_) ._.
          In_IN addition_NN ,_, we_PRP determined_VBD if_IN tyrosine_NN phosphorylation_NN of_IN
          endogenous_JJ FAK_NNP and_CC endogenous_JJ Cas_NNP was_VBD affected_VBN by_IN the_DT
          presence_NN of_IN the_DT chimera_NN ._. This_DT was_VBD not_RB the_DT case_NN ._. Figure_NN
          7_CD bdemonstrates_NNS that_IN there_EX was_VBD no_DT difference_NN in_IN tyrosine_NN
          phosphorylation_NN or_CC association_NN with_IN tyrosine_NN
          phosphorylated_JJ proteins_NNS of_IN either_DT FAK_NNP or_CC endogenous_JJ Cas_NNP
          upon_IN stable_JJ expression_NN of_IN the_DT tyrosine_NN phosphorylated_JJ Cas_NNP
          SD_NNP chimera_NN ._.
        
        
          Tyrosine_NNP phosphorylated_JJ Cas_NNP SD_NNP acts_NNS as_IN a_DT decoy_NN for_IN
          v-crk_JJ and_CC endogenous_JJ c-crk_JJ
          As_IN the_DT tyrosine_NN phosphorylated_JJ Cas_NNP substrate_NN domain_NN
          acts_NNS as_IN a_DT dominant_JJ negative_NN for_IN v-crk_JJ mediated_JJ
          transformation_NN and_CC JNK_NNP activation_NN ,_, and_CC can_MD also_RB interact_NN
          with_IN v-crk_JJ and_CC c-crk_JJ (_( data_NNS not_RB shown_VBN )_) ,_, we_PRP wanted_VBD to_TO
          determine_VB if_IN it_PRP could_MD compete_VB for_IN binding_JJ of_IN v-_NN and_CC c-crk_JJ
          to_TO endogenous_JJ Cas_NNP ._. We_PRP transfected_JJ v-crk_JJ alone_RB or_CC along_IN
          with_IN the_DT chimera_NN of_IN the_DT attenuated_JJ Src_NNP kinase_NN domain_NN
          fused_JJ to_TO the_DT C-_NNP terminal_NN crk_NN interacting_VBG region_NN of_IN the_DT Cas_NNP
          substrate_NN domain_NN (_( Src_NNP *_NN /_NN Cas_NNP (_( 3_CD '_POS SD_NNP )_) ,_, carrying_VBG the_DT YDXP_NNP
          motifs_NNS )_) into_IN Cos-_NNP 7_CD cells_NNS and_CC immunoprecipitated_JJ either_CC
          the_DT chimera_NN or_CC v-crk_JJ and_CC assayed_JJ for_IN interacting_VBG tyrosine_NN
          phosphorylated_JJ proteins_NNS (_( Fig_NNP ._. 8_CD a_DT )_) ._. Our_PRP$ analysis_NN showed_VBD
          that_DT expression_NN of_IN this_DT chimera_NN resulted_VBD in_IN expression_NN of_IN
          the_DT highly_RB tyrosine_NN phosphorylated_JJ Cas_NNP 3_CD '_POS SD_NNP chimera_NN (_( Fig_NNP ._.
          8_CD a_DT ,_, lanes_NNS 2_CD (_( whole_JJ cell_NN lysates_NNS )_) or_CC lane_NN 3_CD ,_, anti-chimera_JJ
          immunoprecipitate_NN )_) ._. Expression_NNP of_IN v-crk_JJ alone_RB resulted_VBD in_IN
          its_PRP$ co-immunoprecipitation_JJ with_IN endogenous_JJ tyrosine_NN
          phosphorylated_JJ Cas_NNP (_( Fig_NNP ._. 8_CD a_DT ,_, lane_NN 4_LS )_) ._. By_IN contrast_NN ,_,
          co-expression_JJ of_IN v-crk_JJ with_IN the_DT chimera_NN resulted_VBD in_IN
          reduction_NN in_IN the_DT association_NN of_IN v-crk_JJ with_IN endogenous_JJ Cas_NNP
          and_CC in_IN induced_VBN association_NN of_IN v-crk_JJ with_IN the_DT tyrosine_NN
          phosphorylated_JJ Cas_NNP 3_CD '_POS SD_NNP (_( Fig_NNP ._. 8_CD a_DT ,_, lane_NN 5_LS )_) ._. To_TO determine_VB
          if_IN the_DT tyrosine_NN phosphorylated_JJ chimera_NN could_MD compete_VB with_IN
          endogenous_JJ Cas_NNP for_IN binding_JJ to_TO endogenous_JJ c-crk_JJ ,_, we_PRP
          transfected_JJ either_CC the_DT isolated_VBN attenuated_JJ Src_NNP kinase_NN
          domain_NN as_IN control_NN ,_, or_CC the_DT tyrosine_NN phosphorylated_JJ Cas_NNP
          substrate_NN domain_NN (_( Src_NNP *_NN /_NN Cas_NNP (_( SD_NNP )_) )_) into_IN Cos-_NNP 7_CD cells_NNS ,_, and_CC
          immunoprecipitated_JJ endogenous_JJ c-crk_JJ (_( Fig_NNP ._. 8_CD b_SYM )_) ._.
          Immunoprecipitation_NNP of_IN endogenous_JJ c-crk_JJ showed_VBD
          association_NN with_IN endogenous_JJ Cas_NNP (_( Fig_NNP ._. 8_CD b_SYM ,_, lane_NN 1_LS )_) ,_, while_IN
          co-expression_JJ of_IN the_DT tyrosine_NN phosphorylated_JJ Cas_NNP
          substrate_NN domain_NN resulted_VBD in_IN reduced_VBN association_NN of_IN
          endogenous_JJ c-crk_JJ with_IN endogenous_JJ Cas_NNP and_CC association_NN with_IN
          the_DT tyrosine_NN phosphorylated_JJ chimera_NN (_( Fig_NNP ._. 8_CD b_SYM ,_, lane_NN 2_LS )_) ._.
          These_DT data_NNS suggest_VBP that_IN the_DT tyrosine_NN phosphorylated_JJ
          substrate_NN domain_NN of_IN Cas_NNP acts_NNS as_IN a_DT decoy_NN for_IN binding_JJ to_TO v-_NN
          and_CC c-crk_JJ thereby_RB interfering_VBG with_IN signaling_VBG to_TO JNK_NNP
          activation_NN and_CC transformation_NN ._.
        
      
      
        Discussion_NNP
        Adaptor_NNP proteins_NNS that_WDT regulate_VB tyrosine_NN kinase_NN signaling_VBG
        pathways_NNS fall_VBP into_IN two_CD major_JJ categories_NNS ,_, those_DT primarily_RB
        with_IN protein_NN /_NN protein_NN interaction_NN domains_NNS such_JJ as_IN SH_NNP 2_CD ,_, SH_NNP 3_CD ,_,
        PTB_NNP ,_, and_CC PH_NNP domains_NNS ,_, exemplified_VBN by_IN the_DT adaptor_NN proteins_NNS
        c-crk_JJ ,_, nck_NN and_CC grb-_NN 2_CD ,_, and_CC those_DT that_WDT are_VBP primarily_RB tyrosine_NN
        phosphorylated_JJ ,_, exemplified_VBN by_IN proteins_NNS such_JJ as_IN Cas_NNP ,_, Dok_NNP ,_,
        IRS-_NNP 1_CD and_CC 2_CD ,_, Slp-_NNP 76_CD ,_, LAT_NNP ,_, TRIM_NNP or_CC SIT_NNP ._. The_DT latter_JJ class_NN may_MD
        also_RB have_VB protein_NN /_NN protein_NN interaction_NN domains_NNS ._. The_DT former_JJ
        class_NN of_IN adaptor_NN proteins_NNS form_VBP complexes_NNS with_IN downstream_JJ
        effectors_NNS in_IN a_DT constitutive_JJ fashion_NN via_IN their_PRP$ SH_NNP 3_CD domains_NNS ._.
        Signals_NNP are_VBP initiated_VBN by_IN tyrosine_NN phosphorylation_NN of_IN
        upstream_JJ effectors_NNS that_WDT recruit_NN these_DT adaptors_NNS to_TO assemble_VB
        larger_JJR protein_NN complexes_NNS by_IN bringing_VBG downstream_JJ effectors_NNS
        to_TO the_DT distinct_JJ cellular_JJ compartments_NNS for_IN activation_NN ._. Thus_RB
        c-crk_JJ interacts_NNS constitutively_RB with_IN downstream_JJ effectors_NNS
        such_JJ as_IN C_NNP 3_CD G_NNP via_IN its_PRP$ SH_NNP 3_CD domains_NNS ,_, and_CC interacts_NNS in_IN a_DT
        phosphotyrosine_NN dependent_JJ fashion_NN with_IN tyrosine_NN
        phosphorylated_JJ receptors_NNS using_VBG its_PRP$ SH_NNP 2_CD domain_NN [_NN 39_CD ]_NN ._. To_TO
        analyze_VB downstream_JJ signals_NNS regulated_VBN by_IN these_DT adaptor_NN
        proteins_NNS ,_, investigators_NNS have_VBP developed_VBN methods_NNS that_WDT target_NN
        them_PRP to_TO distinct_JJ cellular_JJ membrane_NN compartments_NNS by_IN using_VBG
        heterologous_JJ targeting_VBG sequences_NNS ._. This_DT leads_VBZ to_TO the_DT
        generation_NN of_IN constitutive_JJ signals_NNS by_IN the_DT adaptor_NN proteins_NNS
        in_IN the_DT absence_NN of_IN other_JJ upstream_RB signals_VBZ [_NN 40_CD ]_NN ._.
        The_DT second_JJ class_NN of_IN phosphotyrosine_NN dependent_JJ adaptors_NNS
        exemplified_VBN by_IN proteins_NNS such_JJ as_IN Cas_NNP ,_, Dok_NNP ,_, IRS-_NNP 1_CD and_CC 2_CD or_CC
        Slp-_NNP 76_CD ,_, as_IN cytosolic_JJ adaptors_NNS ,_, or_CC LAT_NNP ,_, TRIM_NNP or_CC SIT_NNP as_IN
        membrane_NN anchored_VBN adaptors_NNS ,_, also_RB require_VB the_DT activation_NN of_IN
        upstream_JJ signals_VBZ by_IN tyrosine_NN kinases_NNS for_IN their_PRP$ function_NN ._.
        This_DT second_JJ class_NN of_IN adaptor_NN proteins_NNS is_VBZ characterized_VBN by_IN a_DT
        substrate_NN domain_NN with_IN multiple_JJ tyrosines_NNS for_IN
        phosphorylation_NN by_IN upstream_JJ kinases_NNS ._. Phosphorylation_NNP of_IN
        these_DT sites_NNS leads_VBZ to_TO recruitment_NN of_IN other_JJ proteins_NNS ,_,
        including_VBG the_DT first_JJ class_NN of_IN adaptor_NN proteins_NNS with_IN SH_NNP 2_CD or_CC
        PTB_NNP domains_NNS ,_, and_CC subsequent_JJ signal_NN transmission_NN (_( see_VB [_NN 41_CD ]_NN
        for_IN review_NN )_) ._. Analysis_NNP of_IN the_DT specific_JJ signals_NNS emanating_VBG
        from_IN the_DT second_JJ class_NN of_IN adaptor_NN proteins_NNS has_VBZ been_VBN
        difficult_JJ due_NN to_TO their_PRP$ dependence_NN on_IN upstream_JJ kinases_NNS for_IN
        tyrosine_NN phosphorylation_NN of_IN the_DT substrate_NN domains_NNS for_IN
        subsequent_JJ assembly_NN of_IN downstream_JJ effectors_NNS ._. While_IN these_DT
        upstream_JJ kinases_NNS lead_VBP to_TO tyrosine_NN phosphorylation_NN of_IN the_DT
        adaptor_NN and_CC activation_NN of_IN downstream_JJ effectors_NNS ,_, they_PRP
        usually_RB also_RB activate_VBP other_JJ signaling_VBG pathways_NNS that_WDT can_MD
        confound_NN analysis_NN of_IN the_DT specific_JJ role_NN of_IN the_DT tyrosine_NN
        phosphorylated_JJ adaptor_NN protein_NN ._.
        We_PRP describe_VBP a_DT novel_NN chimeric_JJ molecule_NN approach_NN that_WDT
        allows_VBZ the_DT analysis_NN of_IN signaling_VBG events_NNS regulated_VBN by_IN
        adaptor_NN proteins_NNS that_WDT require_VBP tyrosine_NN phosphorylation_NN by_IN
        upstream_JJ signals_VBZ for_IN which_WDT we_PRP used_VBD the_DT Cas_NNP protein_NN as_IN a_DT
        model_NN ._. The_DT adaptor_NN protein_NN Cas_NNP has_VBZ several_JJ domains_NNS that_WDT are_VBP
        important_JJ for_IN its_PRP$ function_NN ,_, an_DT SH_NNP 3_CD domain_NN ,_, a_DT central_JJ
        substrate_NN domain_NN with_IN up_IN to_TO 15_CD tyrosines_NNS that_WDT can_MD serve_VB as_IN
        tyrosine_NN kinase_NN substrates_NNS for_IN upstream_JJ kinases_NNS such_JJ as_IN Src_NNP
        and_CC Abl_NNP [_NN 19_CD 42_CD 43_CD ]_NN ,_, and_CC a_DT C-_NNP terminal_NN Src_NNP binding_JJ domain_NN
        with_IN PXXP_NNP motifs_NNS for_IN binding_VBG to_TO the_DT SH_NNP 3_CD domain_NN of_IN Src_NNP ,_, and_CC
        two_CD tyrosines_NNS providing_VBG docking_VBG sites_NNS for_IN the_DT Src_NNP SH_NNP 2_CD
        domain_NN upon_IN phosphorylation_NN [_NN 6_CD ]_NN ._. The_DT substrate_NN domain_NN of_IN
        Cas_NNP has_VBZ two_CD major_JJ types_NNS of_IN tyrosine_NN motifs_NNS that_WDT can_MD be_VB
        phosphorylated_JJ and_CC bind_NN downstream_JJ effectors_NNS ,_, YQXP_NNP (_( 4_CD
        copies_NNS )_) and_CC YDXP_NNP motifs_NNS (_( 9_CD copies_NNS )_) ,_, suggesting_VBG that_IN at_IN
        least_JJS two_CD classes_NNS of_IN downstream_JJ effectors_NNS ,_, one_CD capable_JJ of_IN
        binding_JJ to_TO YDXP_NNP motifs_NNS and_CC the_DT other_JJ capable_JJ of_IN binding_JJ to_TO
        YQXP_NNP motifs_NNS ,_, are_VBP assembled_VBN by_IN this_DT adaptor_NN protein_NN ._.
        Tyrosine_NNP phosphorylation_NN of_IN the_DT substrate_NN domain_NN leads_VBZ to_TO
        the_DT recruitment_NN of_IN other_JJ downstream_JJ adaptors_NNS such_JJ as_IN crk_NN
        and_CC nck_NN ,_, as_RB well_RB as_IN other_JJ downstream_JJ effectors_NNS possessing_VBG
        SH_NNP 2_CD domains_NNS ,_, and_CC signaling_VBG events_NNS attributed_VBD to_TO this_DT domain_NN
        include_VBP activation_NN of_IN the_DT JNK_NNP MAPK_NNP pathway_NN and_CC control_NN of_IN
        adhesion_NN and_CC migration_NN of_IN cells_NNS [_NN 6_CD 10_CD 16_CD 38_CD 44_CD ]_NN ._. We_PRP
        constructed_VBN a_DT chimera_NN between_IN a_DT kinase_NN that_IN phosphorylates_NNS
        Cas_NNP 
        in_IN vivo_NN and_CC the_DT substrate_NN domain_NN of_IN
        Cas_NNP ,_, in_IN order_NN to_TO determine_VB events_NNS regulated_VBN by_IN this_DT domain_NN ._.
        We_PRP constructed_VBN chimeras_NNS by_IN placing_VBG the_DT Cas_NNP SD_NNP at_IN either_DT the_DT
        N-_NNP terminus_JJ or_CC C-_NNP terminus_JJ of_IN the_DT Src_NNP kinase_NN domain_NN ._. However_RB ,_,
        we_PRP found_VBD that_IN placing_VBG the_DT Cas_NNP SD_NNP at_IN the_DT N-_NNP terminus_JJ of_IN the_DT
        Src_NNP kinase_NN domain_NN was_VBD inferior_JJ to_TO placing_VBG it_PRP at_IN the_DT
        C-_NNP terminus_JJ with_IN regards_VBZ to_TO tyrosine_NN phosphorylation_NN of_IN the_DT
        Cas_NNP SD_NNP ._. Subsequently_RB ,_, in_IN all_DT our_PRP$ experiments_NNS reported_VBN ,_, we_PRP
        used_VBD chimeras_NNS of_IN the_DT Cas_NNP SD_NNP fused_JJ to_TO the_DT C-_NNP terminus_JJ of_IN the_DT
        Src_NNP kinase_NN domains_NNS ._. Rather_RB than_IN the_DT WT_NNP kinase_NN domain_NN of_IN
        Src_NNP ,_, we_PRP used_VBD an_DT attenuated_JJ Src_NNP kinase_NN domain_NN (_( Y_NNP 416_CD F_NN )_) as_IN the_DT
        fusion_NN partner_NN for_IN our_PRP$ chimera_NN to_TO avoid_VB phosphorylation_NN and_CC
        activation_NN of_IN other_JJ Src_NNP substrates_NNS that_WDT would_MD occur_VB with_IN a_DT
        WT_NNP kinase_NN domain_NN (_( data_NNS not_RB shown_VBN ,_, [_NN 35_CD ]_NN )_) ._. The_DT attenuated_JJ
        Src_NNP kinase_NN domain_NN has_VBZ reduced_VBN kinase_NN activity_NN and_CC does_VBZ not_RB
        phosphorylate_NN exogenous_JJ substrates_NNS [_NN 35_CD ]_NN ._. We_PRP also_RB used_VBD a_DT
        kinase_NN inactive_JJ Src_NNP kinase_NN domain_NN as_IN a_DT control_NN fusion_NN
        protein_NN ._. The_DT chimera_NN of_IN the_DT Cas_NNP SD_NNP domain_NN fused_JJ to_TO the_DT
        attenuated_JJ Src_NNP kinase_NN domain_NN was_VBD highly_RB tyrosine_NN
        phosphorylated_JJ in_IN cells_NNS ,_, and_CC could_MD bind_NN known_VBN Cas_NNP binding_JJ
        proteins_NNS in_IN cells_NNS ._. In_IN contrast_NN ,_, the_DT chimera_NN containing_VBG the_DT
        kinase_NN inactive_JJ domain_NN was_VBD not_RB stably_RB phosphorylated_JJ in_IN
        cells_NNS ._. These_DT findings_NNS indicated_VBD that_IN this_DT approach_NN would_MD be_VB
        useful_JJ in_IN analyzing_VBG the_DT events_NNS that_WDT occur_VBP following_VBG
        tyrosine_NN phosphorylation_NN of_IN the_DT Cas_NNP SD_NNP in_IN the_DT absence_NN of_IN
        upstream_JJ signals_VBZ that_WDT may_MD activate_VBP other_JJ signaling_VBG
        pathways_NNS ._. Our_PRP$ initial_JJ experiments_NNS were_VBD designed_VBN to_TO
        determine_VB whether_IN tyrosine_NN phosphorylation_NN of_IN the_DT SD_NNP of_IN Cas_NNP
        would_MD lead_VB to_TO the_DT assembly_NN of_IN protein_NN complexes_NNS and_CC
        activation_NN of_IN downstream_JJ effectors_NNS ._.
        Using_VBG different_JJ regions_NNS of_IN the_DT Cas_NNP SD_NNP containing_VBG either_CC
        the_DT YDXP_NNP or_CC the_DT YQXP_NNP motifs_NNS ,_, we_PRP could_MD demonstrate_VB that_IN
        v-crk_JJ specifically_RB interacts_NNS with_IN the_DT C-_NNP terminal_NN YDXP_NNP
        motifs_NNS when_WRB tyrosine_NN phosphorylated_JJ ._. Moreover_RB ,_, in_IN the_DT
        absence_NN of_IN stable_JJ tyrosine_NN phosphorylation_NN as_IN seen_VBN in_IN the_DT
        Src_NNP kinase_NN inactive_JJ fusions_NNS ,_, v-crk_JJ could_MD either_CC induce_VB
        their_PRP$ phosphorylation_NN ,_, or_CC protect_VB transiently_RB
        phosphorylated_JJ YDXP_NNP motifs_NNS from_IN dephosphorylation_NN through_IN
        yet_RB unknown_JJ mechanisms_NNS ._. Thus_RB while_IN both_DT sets_NNS of_IN motifs_NNS in_IN
        the_DT Cas_NNP SD_NNP have_VBP been_VBN thought_VBN to_TO interact_NN with_IN the_DT v-crk_JJ SH_NNP 2_CD
        domain_NN ,_, we_PRP demonstrated_VBD that_IN this_DT domain_NN only_RB interacts_NNS
        with_IN the_DT YDXP_NNP motifs_NNS ._. Since_IN crk_NN is_VBZ the_DT major_JJ protein_NN
        reported_VBD to_TO bind_NN to_TO the_DT Cas_NNP SD_NNP ,_, our_PRP$ data_NNS suggest_VBP that_IN the_DT
        YQXP_NNP motifs_NNS may_MD interact_NN with_IN other_JJ yet_RB to_TO be_VB identified_VBN
        downstream_JJ effectors_NNS ._.
        We_PRP also_RB found_VBD that_IN while_IN downstream_JJ effectors_NNS assemble_VBP
        onto_IN the_DT tyrosine_NN phosphorylated_JJ Cas_NNP SD_NNP domain_NN ,_, the_DT
        downstream_JJ signals_NNS were_VBD not_RB activated_VBN ._. In_IN particular_JJ ,_, we_PRP
        found_VBD that_IN the_DT tyrosine_NN phosphorylated_JJ Cas_NNP SD_NNP domain_NN
        blocked_VBD v-crk_JJ mediated_JJ activation_NN of_IN the_DT JNK_NNP pathway_NN ._. In_IN
        addition_NN ,_, we_PRP found_VBD that_DT expression_NN of_IN the_DT tyrosine_NN
        phosphorylated_JJ Cas_NNP SD_NNP domain_NN in_IN v-crk_JJ transformed_VBN cells_NNS
        reduced_VBD their_PRP$ ability_NN to_TO grow_VB in_IN soft_JJ agar_NN ,_, a_DT measure_NN of_IN
        their_PRP$ transformation_NN ._. Furthermore_RB ,_, we_PRP found_VBD that_IN the_DT
        tyrosine_NN phosphorylated_JJ Cas_NNP SD_NNP competed_VBD effectively_RB with_IN
        the_DT endogenous_JJ Cas_NNP for_IN binding_JJ to_TO v-crk_JJ and_CC endogenous_JJ
        c-crk_JJ ,_, while_IN not_RB affecting_VBG tyrosine_NN phosphorylation_NN of_IN
        proposed_VBN upstream_RB proteins_VBZ such_JJ as_IN Fak_NNP and_CC endogenous_JJ Cas_NNP ._.
        Thus_RB ,_, our_PRP$ data_NNS suggest_VBP that_IN the_DT tyrosine_NN phosphorylated_JJ Cas_NNP
        SD_NNP acts_NNS as_IN a_DT decoy_NN for_IN endogenous_JJ Cas_NNP binding_JJ proteins_NNS and_CC
        blocks_NNS signaling_VBG via_IN crk_NN to_TO the_DT activation_NN of_IN JNK_NNP ,_, as_RB well_RB
        as_IN transformation_NN of_IN cells_NNS by_IN the_DT oncogene_NN v-crk_JJ ._. The_DT
        ability_NN of_IN the_DT tyrosine_NN phosphorylated_JJ Cas_NNP SD_NNP to_TO act_VB as_IN a_DT
        decoy_NN suggests_VBZ that_IN while_IN tyrosine_NN phosphorylation_NN of_IN the_DT
        substrate_NN domain_NN of_IN Cas_NNP may_MD be_VB important_JJ for_IN its_PRP$ function_NN
        in_IN assembling_VBG downstream_JJ signals_NNS ,_, specific_JJ localization_NN of_IN
        Cas_NNP may_MD also_RB be_VB critical_JJ for_IN its_PRP$ downstream_JJ functions_NNS ._.
        Indeed_RB ,_, phosphorylated_JJ endogenous_JJ Cas_NNP is_VBZ localized_VBN to_TO FAK_NNP
        and_CC the_DT focal_JJ adhesions_NNS via_IN its_PRP$ SH_NNP 3_CD domain_NN and_CC /_NN or_CC its_PRP$ Src_NNP
        binding_JJ domain_NN in_IN its_PRP$ distal_NN C-_NNP terminus_JJ ,_, both_DT were_VBD excluded_VBN
        from_IN our_PRP$ chimera_NN ,_, suggesting_VBG that_IN proper_JJ localization_NN of_IN
        the_DT tyrosine_NN phosphorylated_JJ substrate_NN domain_NN may_MD be_VB
        required_VBN for_IN Cas_NNP activity_NN [_NN 30_CD 45_CD ]_NN ._.
      
      
        Conclusions_NNP
        A_DT number_NN of_IN proteins_NNS have_VBP been_VBN identified_VBN that_DT bind_NN to_TO
        the_DT substrate_NN domain_NN of_IN Cas_NNP ,_, however_RB the_DT large_JJ number_NN of_IN
        tyrosines_NNS and_CC potential_JJ binding_JJ sites_NNS for_IN downstream_JJ
        effectors_NNS suggest_VBP that_IN there_EX may_MD be_VB more_JJR ._. We_PRP propose_VBP that_IN
        our_PRP$ chimeric_JJ approach_NN can_MD be_VB used_VBN to_TO identify_VB Cas_NNP binding_JJ
        proteins_NNS in_IN mammalian_JJ cells_NNS in_IN the_DT absence_NN of_IN specific_JJ
        upstream_RB signals_VBZ normally_RB required_VBN for_IN tyrosine_NN
        phosphorylation_NN of_IN the_DT Cas_NNP substrate_NN domain_NN ._. We_PRP can_MD also_RB
        use_VB this_DT approach_NN to_TO ask_VB which_WDT tyrosines_NNS within_IN the_DT SD_NNP of_IN
        Cas_NNP can_MD act_VB as_IN decoys_NNS for_IN specific_JJ downstream_JJ signals_NNS
        attributed_VBD to_TO the_DT SD_NNP of_IN Cas_NNP ._. Other_JJ uses_NNS for_IN such_JJ a_DT chimera_NN
        include_VBP screening_NN approaches_NNS such_JJ as_IN the_DT yeast_NN two-hybrid_JJ
        screen_NN to_TO select_VB proteins_NNS that_WDT interact_NN with_IN the_DT tyrosine_NN
        phosphorylated_JJ Cas_NNP SD_NNP ._. Finally_RB ,_, we_PRP can_MD theoretically_RB target_VB
        this_DT tyrosine_NN phosphorylated_JJ chimera_NN to_TO specific_JJ areas_NNS of_IN
        the_DT cell_NN to_TO determine_VB which_WDT cellular_JJ localization_NN will_MD
        recover_VB the_DT activation_NN of_IN downstream_JJ Cas_NNP functions_NNS ._. This_DT
        chimeric_JJ approach_NN can_MD also_RB be_VB extended_VBN to_TO other_JJ adaptor_NN
        proteins_NNS that_WDT require_VBP upstream_RB signals_NNS for_IN tyrosine_NN
        phosphorylation_NN ,_, creating_VBG tyrosine_NN phosphorylated_JJ decoys_NNS or_CC
        targeting_VBG tyrosine_NN phosphorylated_JJ substrate_NN domains_NNS or_CC full_JJ
        length_NN adaptor_NN proteins_NNS in_IN transgenic_JJ cellular_JJ and_CC animal_NN
        systems_NNS ._. We_PRP also_RB propose_VBP that_IN similar_JJ approaches_NNS could_MD be_VB
        used_VBN for_IN analyzing_VBG proteins_NNS that_WDT are_VBP phosphorylated_JJ on_IN
        serine_NN or_CC threonine_NN and_CC assemble_VB complexes_NNS ,_, such_JJ as_IN 14_CD -_: 3_CD -_: 3_CD ,_,
        for_IN analysis_NN of_IN their_PRP$ downstream_JJ signals_NNS or_CC identification_NN
        of_IN binding_JJ proteins_NNS ._.
      
      
        Materials_NNS and_CC Methods_NNP
        
          Materials_NNS
          Antibodies_NNP against_IN the_DT following_VBG proteins_NNS were_VBD
          obtained_VBN from_IN the_DT following_VBG suppliers_NNS or_CC individuals_NNS :_:
          ant-phosphotyrosine_JJ ,_, RC_NNP 20_CD -_: HRP_NNP (_( Transduction_NNP Laboratories_NNPS ,_,
          Lexington_NNP ,_, KY_NNP )_) ;_: anti-_NN HA_NNP (_( Boehringer_NNP Mannheim_NNP ,_,
          Indianapolis_NNP ,_, IN_IN )_) ;_: anti-gag_JJ (_( Dr_NNP ._. R_NN ._. Birge_NNP ,_, New_NNP Jersey_NNP
          Medical_NNP School_NNP ,_, Newark_NNP ,_, NJ_NNP )_) ;_: anti-_NN JNK_NNP (_( NEB_NNP ,_, Beverley_NNP ,_,
          MA_NNP )_) ;_: anti-c-crk_JJ (_( Santa_NNP Cruz_NNP Biotechnology_NNP ,_, Santa_NNP Cruz_NNP ,_,
          CA_NNP )_) ;_: anti-_NN C_NNP 3_CD G_NNP (_( Dr_NNP ._. Beatrice_NNP Knudsen_NNP ,_, Weill_NNP Medical_NNP
          College_NNP of_IN Cornell_NNP University_NNP ,_, NY_NNP ,_, NY_NNP )_) ;_: anti-_NN FAK_NNP and_CC
          anti-_NN Cas_NNP (_( Transduction_NNP Laboratories_NNPS ,_, Lexington_NNP ,_, KY_NNP )_) ._.
        
        
          Cloning_NNP and_CC chimera_NN construction_NN
          The_DT kinase_NN domains_NNS of_IN the_DT c-_NN Src_NNP Y_NNP 416_CD F_NN mutant_JJ (_( kind_NN
          gift_NN of_IN Dr_NNP ._. Joan_NNP Brugge_NNP ,_, Harvard_NNP Medical_NNP School_NNP ,_, Boston_NNP ,_,
          MA_NNP )_) or_CC the_DT kinase_NN inactive_JJ c-_NN Src_NNP (_( K_NNP 295_CD M_NNP ,_, [_NN 46_CD ]_NN )_) ,_, were_VBD
          amplified_VBN by_IN PCR_NNP and_CC cloned_VBN in_IN pJ_NN 3_CD H_NNP and_CC pJ_NN 3_CD M_NNP ,_, two_CD vectors_NNS
          for_IN HA-_NNP and_CC Myc-tagging_NNP at_IN the_DT N-_NNP terminus_JJ of_IN the_DT protein_NN
          (_( kind_NN gifts_NNS from_IN Dr_NNP ._. J_NNP ._. Chernoff_NNP ,_, Fox_NNP Chase_NNP Cancer_NNP
          Center_NNP ,_, Philadelphia_NNP ,_, PA_NNP ,_, [_NN 47_CD ]_NN )_) ._. The_DT pEBG-JNK_JJ was_VBD a_DT
          kind_NN gift_NN of_IN Dr_NNP ._. Bruce_NNP Mayer_NNP (_( Harvard_NNP Medical_NNP School_NNP ,_,
          Boston_NNP ,_, MA_NNP )_) ._. The_DT substrate_NN domain_NN of_IN Cas_NNP (_( Fig_NNP ._. 1_LS ,_, a_DT ._. a_DT ._. L_NNP
          157_CD to_TO R_NN 516_CD )_) was_VBD amplified_VBN by_IN PCR_NNP and_CC fused_JJ in_IN frame_NN to_TO
          the_DT C-_NNP terminus_JJ of_IN the_DT attenuated_JJ SrcY_NNP 416_CD F_NN kinase_NN domain_NN
          (_( Src_NNP *_NN )_) ,_, or_CC to_TO the_DT C-_NNP terminus_JJ of_IN the_DT inactive_JJ SrcK_NNP 295_CD M_NNP
          kinase_NN domain_NN (_( Src_NNP KM_NNP )_) ._. Subfragments_NNP of_IN the_DT Cas_NNP substrate_NN
          domain_NN were_VBD generated_VBN in_IN the_DT same_JJ fashion_NN ,_, with_IN the_DT
          N-_NNP terminal_NN subdomain_NN (_( a_DT ._. a_DT ._. L_NNP 157_CD to_TO A_DT 324_CD ,_, 1_CD YKVP_NNP motif_NN
          and_CC 4_CD YQXP_NNP motifs_NNS )_) and_CC the_DT C-_NNP terminal_NN subdomain_NN (_( a_DT ._. a_DT ._. S_NNP
          325_CD to_TO R_NN 516_CD ,_, 9_CD YDXP_NNP motifs_NNS )_) of_IN Cas_NNP amplified_VBN ._. Experiments_NNS
          used_VBD the_DT chimeras_NNS expressed_VBD either_CC via_IN the_DT pJ_NN 3_CD H_NNP vector_NN ,_,
          or_CC the_DT HA-tagged_NNP chimera_NN subcloned_JJ into_IN the_DT expression_NN
          vector_NN pMEXneo_NN [_NN 48_CD ]_NN ._. The_DT oncogene_NN v-crk_JJ and_CC its_PRP$
          mutants_NNS cloned_VBN into_IN pMEXneo_NN have_VBP been_VBN described_VBN [_NN 49_CD 50_CD ]_NN
          ._.
        
        
          Cell_NNP culture_NN and_CC transfection_NN and_CC soft_JJ agar_NN
          assays_NNS
          Cos-_NNP 7_CD and_CC NIH_NNP 3_CD T_NN 3_CD cells_NNS were_VBD grown_VBN in_IN DMEM_NNP containing_VBG
          10_CD %_NN FCS_NNP and_CC antibiotics_NNS at_IN 37_CD _NN C_NNP with_IN 5_CD %_NN CO_NNP 
          2_CD ._. Cos-_NNP 7_CD cells_NNS were_VBD transfected_JJ by_IN
          calcium_NN phosphate_NN method_NN ,_, while_IN the_DT NIH_NNP 3_CD T_NN 3_CD cells_NNS were_VBD
          transfected_JJ using_VBG Lipofectin_NNP (_( Gibco_NNP ,_, BRL_NNP )_) ._. Growth_NN of_IN
          cells_NNS in_IN soft_JJ agar_NN was_VBD performed_VBN as_IN described_VBN [_NN 51_CD ]_NN
          ._.
        
        
          Cell_NNP Lysis_NNP ,_, Immunoprecipitation_NNP and_CC Kinase_NNP
          Assays_NNP
          Cell_NNP lysis_NNS ,_, Immunoprecipitation_NNP ,_, SDS-PAGE_NNP ,_, and_CC Western_NNP
          blotting_VBG were_VBD performed_VBN exactly_RB as_IN described_VBN [_NN 48_CD ]_NN ._.
          Tyrosine_NNP phosphorylation_NN of_IN chimeras_NNS and_CC other_JJ substrates_NNS
          were_VBD determined_VBN following_VBG immunoprecipitation_NN using_VBG the_DT
          indicated_VBD antibodies_NNS and_CC probing_VBG with_IN RC_NNP 20_CD -_: HRP_NNP
          anti-phosphotyrosine_JJ antibodies_NNS ._. Expression_NNP of_IN the_DT
          chimeras_NNS was_VBD determined_VBN with_IN anti-_NN HA_NNP antibodies_NNS ._. Western_JJ
          blots_NNS were_VBD developed_VBN using_VBG ECL_NNP +_NN (_( Amersham_NNP Pharmacia_NNP )_) ._.
        
      
      
        Author_NN 's_POS contributions_NNS
        AA_NN carried_VBD out_RP the_DT construction_NN of_IN the_DT Src_NNP /_NN Cas_NNP chimeras_NNS ,_,
        and_CC characterized_VBD the_DT chimeras_NNS with_IN the_DT help_NN of_IN MK_NNP ._. AA_NN also_RB
        performed_VBD JNK_NNP assays_NNS in_IN transient_JJ transfections_NNS ,_, analyzed_VBD
        the_DT association_NN of_IN the_DT chimeras_NNS with_IN crk_NN and_CC drafted_VBD the_DT
        manuscript_NN ._. KHK_NNP generated_VBD stable_JJ cell_NN lines_NNS carrying_VBG the_DT
        chimeras_NNS ,_, and_CC characterized_VBD these_DT lines_NNS in_IN soft_JJ agar_NN
        transformation_NN assays_NNS ,_, activation_NN of_IN JNK_NNP ,_, tyrosine_NN
        phosphorylation_NN of_IN FAK_NNP ,_, endogenous_JJ Cas_NNP and_CC association_NN of_IN
        C_NNP 3_CD G_NNP with_IN endogenous_JJ crk_NN ._. AA_NN conceived_VBD of_IN the_DT study_NN and_CC HH_NNP
        provided_VBD intellectual_JJ input_NN ._. The_DT manuscript_NN was_VBD written_VBN
        with_IN the_DT input_NN of_IN all_PDT the_DT authors_NNS and_CC all_DT authors_NNS read_VBP and_CC
        approved_VBD the_DT final_JJ version_NN of_IN the_DT manuscript_NN ._.
      
    
  
